Bromide

Bromide

SCHEMBL9718283

Br.CC(C)C(C)(C)[Si](C)(C)OCCc1ccccc1

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
SIGMAR1 known ✓ Q99720 2/20 0.33
IDO1 P14902 1/20 0.37
DHFR P00374 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 1/20 0.34
TRPA1 O75762 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9813441 0.83 MEN1 (0.38)
SCHEMBL9813460 0.83 CYP4F2 (0.40) CA1CA2CA9
SCHEMBL9699720 0.83 TAAR1 (0.36) IDO1SIGMAR1
SCHEMBL9185281 0.81 IDO1 (0.42) IDO1SMN1; SMN2CA1CA2CA9
SCHEMBL9198674 0.81 TAAR1 (0.42) IDO1SIGMAR1
SCHEMBL9699643 0.80 MEN1 (0.30)
SCHEMBL9699540 0.80
SCHEMBL9566318 0.77 TAAR1 (0.39) IDO1CA9
SCHEMBL10392875 0.76 VDR (0.31)
SCHEMBL9700881 0.75 S1PR2 (0.31) IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5153327-A 7-Oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease E. R. SQUIBB & SONS, INC. (US) 1992-10-06 US disclosed
US-5100889-A Thromboxane A2 receptor antagonists, thromboxane synthetase inhibitor E. R. SQUIBB & SONS, INC. (US) 1992-03-31 US disclosed